Table 2.
Adjusted analysis for diagnoses of atrial fibrillation, atrial flutter, and fast atrial tachycardia in participants without atrial fibrillation, atrial flutter, or fast atrial tachycardia at baseline, stratified by analysis subgroup
| Population | Intervention | Control | Difference | |||||
|---|---|---|---|---|---|---|---|---|
| N | Cases (%) | N | Cases (%) | OR | Lower CI | Upper CI | P-value | |
| Full analysis population | 11 849 | 116 (0.98) | 11 896 | 114 (0.96) | 1.07 | 0.82 | 1.39 | 0.625 |
| High-risk population | 906 | 51 (5.63) | 974 | 48 (4.93) | 1.15 | 0.77 | 1.73 | 0.486 |
| Research clinic population | 255 | 24a (9.41) | 973 | 48 (4.93) | 2.24 | 1.31 | 3.73 | 0.003 |
| Per-protocol population | 148 | 15 (10.14) | 876 | 39 (4.45) | 3.07 | 1.57 | 5.81 | 0.001 |
CI, 95% confidence interval; OR, odds ratio.
a
Thirteen diagnoses were a direct result of the trial intervention, and the remaining 11 diagnoses were a result of routine care during the trial period.